Stocks of Pfizer vaccine arrive in Northern Ireland earlier than planned

Stocks of coronavirus vaccine have arrived in Northern Ireland ahead of the rollout of the jabs next week.
Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

The initial batch of the Pfizer/BioNTech vaccine were transported overnight from England.

It has been taken to a central storage facility, the location of which is not being disclosed.

Hide Ad
Hide Ad

The delivery means Northern Ireland remains on track to start administering the vaccine to healthcare workers next week.

Elderly people in care homes and their carers are top of the list to receive a Covid-19 vaccine after the UK became the first country in the world to approve a jab from Pfizer and BioNTech.Elderly people in care homes and their carers are top of the list to receive a Covid-19 vaccine after the UK became the first country in the world to approve a jab from Pfizer and BioNTech.
Elderly people in care homes and their carers are top of the list to receive a Covid-19 vaccine after the UK became the first country in the world to approve a jab from Pfizer and BioNTech.

Health minister Robin Swann visiting one of Northern Ireland’s seven mass vaccination centres (Presseye/PA).

It is understood the 800-plus team of vaccinators will be the first to receive the jabs.

Healthcare workers across the region will be able to get the vaccine through the remainder of December at seven centres spread across the region.

Hide Ad
Hide Ad

Two of the facilities are located on hospital grounds – at the Ulster Hospital in Dundonald and Belfast’s Royal Victoria Hospital – and the rest in leisure centres.

The centres will operate 12 hours a day and seven days a week in an effort to vaccinate 100,000 healthcare and care home staff. Care home residents and people aged over 80 are also in the first priority vaccination group.

Health officials continue to examine ways to administer the Pfizer/BioNTech vaccine in care homes in Northern Ireland.

The size of batches and the extremely low temperature at which it must be stored poses logistical challenges with using the vaccine outside the major centres.

Hide Ad
Hide Ad

The majority of care home residents may ultimately receive another brand of vaccine, with health chiefs hopeful that regulatory approval for the Oxford/AstraZeneca vaccine could be only a matter of days away.

That product does not come with the same storage and batch size constraints.

Comment Guidelines

National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.